FTC Supports March-In Rights to Control Prices and Stimulate Competition

The Federal Trade Commission (FTC) has waded into the march-in rights fracas, supporting the obscure Bayh-Dole Act as a tool to moderate drug pricing and control patent thickets on drugs developed with federal funding.
Source: Drug Industry Daily